Activity of the caspase-3/CPP32 enzyme is increased in “early stage” myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro
- 1 July 2000
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 28 (7) , 784-791
- https://doi.org/10.1016/s0301-472x(00)00179-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transductionBritish Journal of Haematology, 1999
- Correlation of tumor necrosis factor α (TNFα) with high Caspase 3-like activity in myelodysplastic syndromesPublished by Elsevier ,1999
- Inhibition of Human Caspases by Peptide-based and Macromolecular InhibitorsJournal of Biological Chemistry, 1998
- Ineffective haemopoiesis and apoptosis in myelodysplastic syndromesBritish Journal of Haematology, 1998
- Apoptosis by Death FactorCell, 1997
- The myelodysplastic syndromes in 1996: Complex stem cell disorders confounded by dual actions of cytokinesLeukemia Research, 1996
- Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromesLeukemia Research, 1996
- Is apoptosis a massive process in myelodysplastic syndromes?British Journal of Haematology, 1996
- Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell DeathCell, 1996
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995